학술논문
FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim-Chester Disease with the BRAFV600 Mutation
Document Type
Article
Author
Source
In: Oncologist . (Oncologist, December 2018, 23(12):1520-1524)
Subject
Language
English
ISSN
1549490X
10837159
10837159